Minimal residual disease (MRD) detection is crucial in lymphoma management as it predicts relapse risk and guides therapeutic decisions. Traditional MRD methods often involve invasive biopsies, leading to patient https://gretascte815534.activoblog.com/43739652/liquid-biopsy-for-minimal-residual-disease-detection-in-lymphoma